Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 4
1995 6
1996 1
1997 4
1998 2
1999 4
2001 3
2002 3
2013 1
2014 2
2018 1
2019 5
2020 4
2021 1
2022 1
2023 4
2024 3
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Remibrutinib in Chronic Spontaneous Urticaria.
Metz M, Giménez-Arnau A, Hide M, Lebwohl M, Mosnaim G, Saini S, Sussman G, Szalewski R, Haemmerle S, Lheritier K, Martzloff ED, Seko N, Wang P, Zharkov A, Maurer M; REMIX-1 and REMIX-2 Investigators; REMIX-1 Investigators; REMIX-2 Investigators. Metz M, et al. N Engl J Med. 2025 Mar 6;392(10):984-994. doi: 10.1056/NEJMoa2408792. N Engl J Med. 2025. PMID: 40043237 Clinical Trial.
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.
Kimball AB, Jemec GBE, Alavi A, Reguiai Z, Gottlieb AB, Bechara FG, Paul C, Giamarellos Bourboulis EJ, Villani AP, Schwinn A, Ruëff F, Pillay Ramaya L, Reich A, Lobo I, Sinclair R, Passeron T, Martorell A, Mendes-Bastos P, Kokolakis G, Becherel PA, Wozniak MB, Martinez AL, Wei X, Uhlmann L, Passera A, Keefe D, Martin R, Field C, Chen L, Vandemeulebroecke M, Ravichandran S, Muscianisi E. Kimball AB, et al. Among authors: becherel pa. Lancet. 2023 Mar 4;401(10378):747-761. doi: 10.1016/S0140-6736(23)00022-3. Epub 2023 Feb 3. Lancet. 2023. PMID: 36746171 Clinical Trial.
[Facial edema].
Pernès JM, Carcone B, Becherel PA, Hamrouni A. Pernès JM, et al. Among authors: becherel pa. Rev Med Interne. 2014 May;35(5):341-3. doi: 10.1016/j.revmed.2013.07.003. Epub 2013 Aug 16. Rev Med Interne. 2014. PMID: 23958231 French. No abstract available.
Combining Omalizumab with Another Biotherapy.
Fougerousse AC, Becherel PA, Pallure V, Boyé T, Reguiai Z, Gabison G, Barthelemy H, Badaoui A, Mahé E, Livideanu CB; GEM ResoPso. Fougerousse AC, et al. Among authors: becherel pa. Acta Derm Venereol. 2019 Apr 1;99(4):448-449. doi: 10.2340/00015555-3140. Acta Derm Venereol. 2019. PMID: 30723874 Free article. No abstract available.
Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study.
Calabrese L, Cinotti E, D'Onghia M, Cartocci A, Rubegni P, Maccari F, Boulard C, Reguiai Z, Becherel PA, Jacobzone C, Begon E, Fite C, Walls B, Liegeon AL, Parier J, Chaby G, Perrot JL; Omcci Group. Calabrese L, et al. Among authors: becherel pa. Acta Derm Venereol. 2025 Mar 12;105:adv42275. doi: 10.2340/actadv.v105.42275. Acta Derm Venereol. 2025. PMID: 40077977 Free article.
Evolution of dupilumab-associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (RESO-ADOC study).
Reguiai Z, Becherel PA, Perrot JL, Boulard C, Fougerousse AC, Begon E, Badaoui A, Poreaux C, Parier J, Liegeon AL, Levavasseur M, Bing AC, Estève E, Maccari F; GEM reso‐Dermatologie and OMCCI Group. Reguiai Z, et al. Among authors: becherel pa. J Eur Acad Dermatol Venereol. 2024 Nov;38(11):2149-2155. doi: 10.1111/jdv.20233. Epub 2024 Jul 17. J Eur Acad Dermatol Venereol. 2024. PMID: 39015045
Compared Burden of Psoriasis, Atopic Dermatitis, Hidradenitis Suppurativa, and Chronic Urticaria: Baseline Characteristics of the Patients Included in the OMCCI Cohort - A French, Prospective Multicenter Study of Chronic Inflammatory Dermatoses.
Becherel PA, Reguiai Z, Fougerousse AC, Perrot JL, Begon E, Thomas-Beaulieu D, Mery-Bossard L, Pourchot D, Boulard C, Fite C, Beaziz J, Zaraa I, Lons-Danic D, Badaoui A, Parier J, Chaby G, Estève E, Liegeon AL, Patchinsky A, Muller P, Lepelley-Dupont C, Poreaux C, Jacobzone-Lévêque C, Chassain K, Mohty R, Perrussel M, Garcia C, Girard C, Dillies AS, Amy de la Breteque M, Quiles-Tsimaratos N, Denis D, Maccari F. Becherel PA, et al. Dermatology. 2024;240(5-6):702-712. doi: 10.1159/000540250. Epub 2024 Jul 17. Dermatology. 2024. PMID: 39019015
The full range of ophthalmological clinical manifestations in systemic lupus erythematosus.
Kedia N, Theillac V, Paez-Escamilla M, Indermill C, Gallagher DS, Adam R, Qu-Knafo AL, Amari F, Bottin C, Chotard G, Caillaux V, Strého M, Sedira N, Héron E, Becherel PA, Bodaghi B, Mrejen-Uretski S, Sahel AJ, Saadoun D, Errera MH. Kedia N, et al. Among authors: becherel pa. Front Ophthalmol (Lausanne). 2023 Jan 26;2:1055766. doi: 10.3389/fopht.2022.1055766. eCollection 2022. Front Ophthalmol (Lausanne). 2023. PMID: 38983519 Free PMC article.
55 results